BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19517088)

  • 1. [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].
    Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Erbersdobler A; Stephan C; Jung K
    Urologe A; 2009 Aug; 48(8):877-85. PubMed ID: 19517088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and cancer: current state and future perspectives in urologic oncology.
    Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Stephan C; Jung K
    Urol Oncol; 2010; 28(1):4-13. PubMed ID: 19117772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as new diagnostic and prognostic biomarkers in urological tumors.
    Fendler A; Jung K
    Crit Rev Oncog; 2013; 18(4):289-302. PubMed ID: 23614616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: a new paradigm on molecular urological oncology.
    Reis LO; Pereira TC; Lopes-Cendes I; Ferreira U
    Urology; 2010 Sep; 76(3):521-7. PubMed ID: 20472270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The translational potential of microRNAs as biofluid markers of urological tumours.
    Fendler A; Stephan C; Yousef GM; Kristiansen G; Jung K
    Nat Rev Urol; 2016 Dec; 13(12):734-752. PubMed ID: 27804986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
    Mlcochova H; Hezova R; Stanik M; Slaby O
    Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MicroRNAs as potential noninvasive markers in the diagnosis of urological malignancies].
    Gilyazova IR; Klimentova EA; Pavlov VN; Khusnutdinova EK
    Urologiia; 2016 Apr; (2):96-102. PubMed ID: 28247670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of microRNAs in bladder cancer.
    Enokida H; Yoshino H; Matsushita R; Nakagawa M
    Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.
    Schaefer A; Stephan C; Busch J; Yousef GM; Jung K
    Nat Rev Urol; 2010 May; 7(5):286-97. PubMed ID: 20368743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [miRNAs in cancer: the case of liver tumors].
    Ladeiro Y; Zucman-Rossi J
    Med Sci (Paris); 2009 May; 25(5):467-72. PubMed ID: 19480827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
    Blenkiron C; Goldstein LD; Thorne NP; Spiteri I; Chin SF; Dunning MJ; Barbosa-Morais NL; Teschendorff AE; Green AR; Ellis IO; Tavaré S; Caldas C; Miska EA
    Genome Biol; 2007; 8(10):R214. PubMed ID: 17922911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis.
    Chen Z; Zhan Y; Chi J; Guo S; Zhong X; He A; Zheng J; Gong Y; Li X; Zhou L
    EBioMedicine; 2018 Aug; 34():94-107. PubMed ID: 30037718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
    Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
    BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiling of male breast cancer.
    Fassan M; Baffa R; Palazzo JP; Lloyd J; Crosariol M; Liu CG; Volinia S; Alder H; Rugge M; Croce CM; Rosenberg A
    Breast Cancer Res; 2009; 11(4):R58. PubMed ID: 19664288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research.
    Hu Y; Ehli EA; Boomsma DI
    Autism Res; 2017 Jul; 10(7):1184-1203. PubMed ID: 28419777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA biogenesis, functionality and cancer relevance.
    Kusenda B; Mraz M; Mayer J; Pospisilova S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):205-15. PubMed ID: 17426780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling.
    Ferdin J; Kunej T; Calin GA
    Technol Cancer Res Treat; 2010 Apr; 9(2):123-38. PubMed ID: 20218735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.